Guillaume Pfefer
Vorstandsvorsitzender bei Sail Biomedicines
Profil
Guillaume Pfefer is the founder of Sail Biomedicines.
He is currently the CEO-Partner at Flagship Pioneering.
Previously, he served as Co-President & Chief Executive Officer at KALA BIO, Inc., President, Chief Executive Officer & Treasurer at Senda Biosciences, Inc., Principal at Aventis SA and Rhone-Poulenc SA, and Vice President & Global Head-Corporate Strategy at Sanofi Pasteur SA de CV.
Pfefer holds a doctorate from Université de Lorraine and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Guillaume Pfefer
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01.06.2020 |
Sail Biomedicines
 Sail Biomedicines Pharmaceuticals: MajorHealth Technology Sail Biomedicines was founded in 2023 by Guillaume Pfefer. The American company engages in the design and deployment of programmable medicines. Guillaume Pfefer has been the CEO since 2023. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Guillaume Pfefer
| Unternehmen | Position | Ende |
|---|---|---|
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | - |
| Rhone-Poulenc SA | Corporate Officer/Principal | - |
Sanofi Pasteur SA de CV
 Sanofi Pasteur SA de CV BiotechnologyHealth Technology Part of Sanofi, Sanofi Pasteur SA de CV is a Mexican company that develops, manufactures and supplies vaccines. The company is based in Coyoacán, Mexico. | Corporate Officer/Principal | - |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Corporate Officer/Principal | - |
| KALA BIO, INC. | Vorstandsvorsitzender | - |
Ausbildung von Guillaume Pfefer
| Université de Lorraine | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Rhone-Poulenc SA | Process Industries |
Sanofi Pasteur SA de CV
Sanofi Pasteur SA de CV BiotechnologyHealth Technology Part of Sanofi, Sanofi Pasteur SA de CV is a Mexican company that develops, manufactures and supplies vaccines. The company is based in Coyoacán, Mexico. | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Sail Biomedicines
Sail Biomedicines Pharmaceuticals: MajorHealth Technology Sail Biomedicines was founded in 2023 by Guillaume Pfefer. The American company engages in the design and deployment of programmable medicines. Guillaume Pfefer has been the CEO since 2023. | Health Technology |
